Search for: "In Re: Fosamax Products Liability Litigation"
Results 81 - 98
of 98
Sort by Relevance
|
Sort by Date
29 Nov 2009, 12:06 am
The broader litigation in the same court is In re Fosamax Products Liability Litigation, No. 06-1789. [read post]
15 Nov 2009, 6:18 pm
The latest "fad" among defense lawyers — more on the source of the word "fad" in a moment — is to hire companies to monitor state court dockets for suits against big corporations, particularly class actions alleging product liability. [read post]
1 Oct 2009, 2:14 am
While we're on the subject, can we get judges to rewrite the New Jersey and Minnesota statutes of limitations to add a borrowing statute? [read post]
13 Sep 2009, 12:12 am
The case is In re Fosamax Products Liability Litigation, U.S. [read post]
10 Sep 2009, 1:25 am
The federal lawsuits are combined in In Re Fosamax Products Liability Litigation, MDL 1789, U.S. [read post]
9 Sep 2009, 12:26 am
" The case is In Re: Fosamax Products Liability Litigation 06-md-01789 in U.S. [read post]
13 Aug 2009, 9:19 am
The New York suits are combined in In Re Fosamax Products Liability Litigation, MDL 1789, U.S. [read post]
11 Aug 2009, 9:19 am
The New York suits are combined in In Re Fosamax Products Liability Litigation, MDL 1789, U.S. [read post]
4 Aug 2009, 1:15 am
The lawsuits are combined in In Re Fosamax Products Liability Litigation, MDL 1789, U.S. [read post]
30 Jul 2009, 7:02 am
At the present time, about 700 Fosamax lawsuits filed in the federal court system have been consolidated in In Re Fosamax Products Liability Litigation, MDL 1789, U.S. [read post]
10 Mar 2009, 3:03 am
DISTRICT COURTSOUTHERN DISTRICT OF NEW YORKCivil Practice
Fosamax Plaintiffs Must Advance Merck the Costs Of Deposing Their Expert Witness in Australia
In re: Fosamax Products Liability Litigation
Subscription Required
U.S. [read post]
31 Oct 2008, 11:53 am
You can separately subscribe to the Pharma & Biotech edition of the IP Think Tank Global Week in Review by subscribing by email, or selecting ‘all posts’ or ‘Pharma, Biotech & Chem’ for the RSS option at the Subscribe page: [duncanbucknell.com] Highlights this week included: Oxytrol (Oxybutynin) - US: Watson files patent infringement lawsuit against Barr over application to market generic Oxytrol; Barr challenges Oxytrol patent… [read post]
2 Aug 2008, 12:54 am
: (Holman’s Biotech IP Blog), Daiichi’s open offer for 20% in Ranbaxy awaits Sebi nod: (GenericsWeb), Australia/India: Strides shows thumbs up for Indian generic industry acquiring controlling interest in Ascent: (Spicy IP), Europe: Significant date ahead for EU Paediatric Regulation: (SPC Blog), India: Grave diggers, ‘immoral’ patent and the National Biotech Regulatory Authority: (Spicy IP), UK: Monster trade mark infringement case: court reveals its thinking… [read post]
16 Jul 2008, 12:00 pm
Contact Lens Solution Products Liability Litigation (we'll call this a borderline MDL for this list)MDL-1789 IN RE Fosamax Products Liability LitigationMDL-1836 IN RE Mirapex Products Liability LitigationMDL-1842 IN RE Kugel Mesh Hernia Patch Products Liability LitigationBecause we've copied this list from the MDL Panel website, each case name links to slightly more… [read post]
11 Jul 2008, 4:30 am
Part I – Spicy IP), India: Discussion of grant of Indian patents to Cipla for Fosamax derivative and Nexium derivative: (Spicy IP), India: Draft National Biotechnology Regulatory Authority Bill: (Spicy IP), Ivory Coast: Ivorians increasingly choose fake medicines on price: (Afro-IP), Mexico: New Mexican medicaments approvals regime: an early report: (IP tango), UK: Leave to appeal refused in trade mark infringement proceedings between Eli Lilly and 8PM Chemist concerning the… [read post]
5 Jul 2008, 11:05 am
: (IP tango), China: Pfizer loses trade mark action against Jaingsu Lianhuan Pharmaceutical Co over 3D mark: (Rouse & Co International), India: More patents for new forms issued to generics: (Patent Circle), India: Gauri Kamath on drug ‘differential pricing’ in India: (Spicy IP), Mexico: Revised health supplies regulations promise changes for generics: (International Law Office), US: World drug pricing crisis: Congressmen criticise US Trade Representative over Special 301… [read post]
15 Feb 2008, 9:00 am
A step behind: (Spicy IP),Proposals for ISPs to terminate infringers go (even more) global: (LawFont.com),Five ways to minimize risk of copyright liability from citizen media: (IP ADR Blog), Pharma & BiotechPharma & Biotech - GeneralMillennium Pharmaceuticals spent $1.28 million on lobbying for patent reform and biologics legislation in 2007: (Patent Docs),New Thai Minister may review compulsory licences on cancer drugs: (Intellectual Property… [read post]
11 Jan 2008, 4:49 am
One of Bexis' Vioxx pals (he's not sure who, since it was sent by fax and cover page was removed - next time use PDF) at Hughes Hubbard passed it along, and when Bexis returned to reality, he shared.Good thing, too.The decision, now available electronically, is In re Fosamax Products Liability Litigation, 2008 WL 58890 (S.D.N.Y. [read post]
